Ergoteles LLC - SEELOS THERAPEUTICS INC ownership

SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 86 filers reported holding SEELOS THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.

Quarter-by-quarter ownership
Ergoteles LLC ownership history of SEELOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$416,000
+26.4%
403,508
-16.4%
0.02%
+50.0%
Q2 2022$329,000
-39.6%
482,900
+342.0%
0.01%
-41.2%
Q1 2021$545,000109,2570.02%
Other shareholders
SEELOS THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 508,000$249,0000.10%
1492 Capital Management LLC 150,000$74,0000.09%
Uniplan Investment Counsel, Inc. 2,069,121$1,014,0000.08%
ARDSLEY ADVISORY PARTNERS LP 70,000$34,0000.01%
Spark Investment Management LLC 35,210$17,0000.01%
TOCQUEVILLE ASSET MANAGEMENT L.P. 191,000$94,0000.00%
WealthPLAN Partners, LLC 20,000$15,0000.00%
Procyon Advisors, LLC 2,500$1,0000.00%
Renaissance Technologies 1,078,379$529,0000.00%
WELLS FARGO & COMPANY/MN 203$00.00%
View complete list of SEELOS THERAPEUTICS INC shareholders